Aug 04, 2022 7:00am EDT XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
Jul 13, 2022 7:00am EDT XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
Jul 07, 2022 7:00am EDT XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)